Movement for Depression - An RCT Assessing the Effects of Physical Activity Promotion for People With MDD

Hospital de Clinicas de Porto Alegre130 enrolled

Overview

Randomized clinical trial that aims to increase physical activity levels in people with depression and to evaluate if the increase on PA levels has impact on clinical and biological measures.

The contacts will be made by face-to-face interviews and telephone calls

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

130

Conditions

Major Depressive Disorder

Interventions

Physical activity promotion + TAUBEHAVIORAL

Pedometer: Each patient will receive a pedometer with increasing weekly aims on number of steps during the trial. The number of steps to be achieved starts on 4.000 and increases progressively until the end of the trial. Behavioral strategy based on STD theory, and the assessment of barriers and facilitators of each patient. All patients were receiving treatment as usual

ControlBEHAVIORAL

Weekly call on general health aspects + treatment as usual

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * age: 18 - 65 years; * diagnosis of Major Depressive Disorder (DSM-IV), assessed by a trained psychiatrist; * score 7 or more in the HAM-D; * do not present clinical comorbidities that limit or contra-indicate the practice of physical activity; * be starting depression treatment at the Programa de transtorno do humor (PROTHUM) ; * have acess to a computer and have a facebook account; * be able to read and sign the consent term. Exclusion Criteria: * present other psychiatric diagnosis such as bipolar disorder, schizophrenia or use of alcohol or other drugs; * be not liberated to the practice of physical exercises by the assistant psychiatrist.

Locations (1)

Hospital de Clínicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

RECRUITING

Outcomes

Primary Outcomes

Depressive symptoms (blinded assessment)

Hamilton scale for depressive symptoms assessed by a blinded psychiatrist. Clinician-administered semi-structured interview with 17 questions. It is designed to measure the severity of depressive symptoms in patients with a primary depressive illness. Higher scores means higher depressive symptoms. The cutoffs are the following: following severity ranges for the HAMD: no depression (0-7); mild depression (8-16); moderate depression (17-23); and severe depression (≥24). The maximum score is 52.